There are several neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) where NLRP3 mediated chronic inflammation plays a crucial role in the pathological progression (Tan et al., 2013; Cho et al., 2014). This evidence concerns the gene NLRP3 and early-onset autosomal dominant Alzheimer disease.